tert-Butyl 4-(2-aminopyridin-4-yl)piperazine-1-carboxylate
95%
- Product Code: 150696
CAS:
571189-23-6
| Molecular Weight: | 278.35 g./mol | Molecular Formula: | C₁₄H₂₂N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD11849292 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
Used as an important intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in creating drug candidates targeting neurological disorders and inflammatory diseases. Commonly employed in medicinal chemistry for building pyridine- and piperazine-based bioactive molecules due to its stability and reactivity profile.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿3,200.00 |
+
-
|
| 250mg | 10-20 days | ฿6,400.00 |
+
-
|
| 1g | 10-20 days | ฿19,200.00 |
+
-
|
| 5g | 10-20 days | ฿48,000.00 |
+
-
|
tert-Butyl 4-(2-aminopyridin-4-yl)piperazine-1-carboxylate
Used as an important intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in creating drug candidates targeting neurological disorders and inflammatory diseases. Commonly employed in medicinal chemistry for building pyridine- and piperazine-based bioactive molecules due to its stability and reactivity profile.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :